Parp3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PARP3 (Poly(ADP-Ribose) Polymerase 3) is a 60 kDa protein encoded by the PARP3 gene (3p21.2) that functions as an ADP-ribosyltransferase involved in DNA damage response and cell division regulation. [@parp2023]
...
PARP3 Protein
Introduction
Parp3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PARP3 (Poly(ADP-Ribose) Polymerase 3) is a 60 kDa protein encoded by the PARP3 gene (3p21.2) that functions as an ADP-ribosyltransferase involved in DNA damage response and cell division regulation. [@parp2023]
Central catalytic domain with ADP-ribosyltransferase activity
BRCT domains for DNA damage recognition
WGR domain for nucleic acid binding
Normal Function
DNA Damage Response
Sensor of DNA double-strand breaks
Promotes alt-EJ pathway for DNA repair
Interacts with PARP1 and PARP2 complexes
Regulates chromatin accessibility
Cell Cycle Regulation
Localizes to centromeres during mitosis
Regulates mitotic spindle assembly
Controls chromosome segregation
Essential for proper cell division
Role in Disease
Cancer
Overexpression in multiple cancer types
Promotes tumor cell survival under genotoxic stress
Potential target for PARP3-selective inhibitors
Synthetic lethality with DNA repair defects
Neurodegeneration
May affect neuronal DNA repair capacity
Potential role in age-related neurodegeneration
Involvement in Alzheimer's and Parkinson's disease being investigated
DNA repair deficits in neurodegenerative conditions
Therapeutic Implications
| Strategy | Agent | Status | |----------|-------|--------| | PARP3 inhibitors | Under development | Preclinical | | Combination therapy | With radiation/chemo | Research |
Alternative Splicing and Isoforms
PARP3 exists in multiple isoforms generated through alternative splicing. The predominant isoform is a 65 kDa protein that localizes predominantly to the nucleus. Alternative splicing events can affect the N-terminal regulatory domain and may influence protein-protein interactions and catalytic activity. Studies have identified at least three different splice variants with varying expression patterns across tissues.
DNA Repair Mechanisms
PARP3 participates in several DNA repair pathways:
Base Excision Repair (BER): PARP3 collaborates with PARP1 in repairing oxidative DNA damage through the BER pathway. While PARP1 is the primary sensor of single-strand breaks, PARP3 provides backup activity and ensures complete repair.
Double-Strand Break Repair: PARP3 interacts with the DNA-dependent protein kinase (DNA-PK) complex in the non-homologous end joining (NHEJ) pathway. This interaction is particularly important for V(D)J recombination in lymphocytes.
Chromatin Remodeling: PARP3-mediated poly-ADP-ribosylation facilitates chromatin relaxation at damage sites, allowing access to repair machinery. This function is coordinated with histone modifiers and ATP-dependent chromatin remodelers.
Neurodegenerative Disease Relevance
The role of PARP3 in DNA repair has important implications for neurodegeneration:
Alzheimer's Disease: Elevated PARP3 activity has been observed in AD brains, particularly in regions with significant neuronal loss. The relationship between PARP3 activation and disease progression remains an active area of investigation.
Parkinson's Disease: PARP3 may contribute to dopaminergic neuron vulnerability through its role in managing oxidative DNA damage. Studies in PD models suggest that PARP inhibition could be protective.
Stroke and Ischemia: Following cerebral ischemia, PARP3 is activated in response to DNA damage from oxidative stress. The extent of PARP3 activation correlates with the severity of neuronal injury.
Therapeutic Targeting
PARP3-specific inhibitors are being developed for:
Cancer therapy in combination with DNA-damaging agents
Neuroprotection in acute and chronic neurodegenerative conditions
Enhancement of DNA repair in age-related neurodegeneration
The study of Parp3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[^1] Ame JC, Spenlehauer C, de Murcia G, The PARP superfamily (2024)
[^2] Demyanenko S, et al, PARP3 regulates chromatin remodeling (2023)
[^3] Rulten SL, et al, PARP3 in cellular response to genotoxic stress (2022)
[^4] Loseva P, et al, PARP3 is a DNA-damage-responsive adaptor (2021)
[^5] Frizzell KM, et al, PARP3 specifically interacts with PARP1 (2019)